Please login to the form below

Not currently logged in
Email:
Password:

CAD106

This page shows the latest CAD106 news and features for those working in and with pharma, biotech and healthcare.

AZ gets $100m from Lilly as Alzheimer's drug progresses

AZ gets $100m from Lilly as Alzheimer's drug progresses

Meanwhile, Novartis and Amgen are co-developing a BACE inhibitor called CNP520 in combination with investigational immunotherapy CAD106 in people at risk of developing AD dementia, recently starting a phase

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics